The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study
John W. Frew, Kristina Navrazhina, David Grand, Mary Sullivan‐Whalen, Patricia Gilleaudeau, Sandra Garcet, Jonathan Ungar, James G. Krueger
Topics & Concepts
MedicineHidradenitis suppurativaAdverse effectAdalimumabTolerabilityInternal medicineAnakinraDermatologyDiseaseHidradenitis Suppurativa and TreatmentsAcne and Rosacea Treatments and EffectsAnorectal Disease Treatments and Outcomes